Heartflow (NASDAQ:HTFL) Stock Price Target Raised at Stifel Nicolaus

Heartflow (NASDAQ:HTFL) had its target price hoisted by Stifel Nicolaus from $45.00 to $70.00 in a research report sent to investors on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock.

Several other research firms have also recently commented on HTFL. Wells Fargo & Company boosted their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Heartflow in a research note on Wednesday, November 4th. Morgan Stanley raised their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Wall Street Zen downgraded shares of Heartflow from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Finally, Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $60.12.

Heartflow Price Performance

Shares of HTFL traded down $11.46 during midday trading on Friday, hitting $48.46. The stock had a trading volume of 3,705,135 shares, compared to its average volume of 1,763,967. The firm has a market cap of $4.21 billion, a price-to-earnings ratio of -52.67 and a beta of 2.50. The company has a 50 day simple moving average of $51.91 and a two-hundred day simple moving average of $35.23. Heartflow has a twelve month low of $20.13 and a twelve month high of $60.65.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.15. The company had revenue of $72.86 million during the quarter. Heartflow had a negative return on equity of 20.42% and a negative net margin of 33.11%. During the same period in the prior year, the company earned ($0.27) earnings per share. Analysts forecast that Heartflow will post -0.75 EPS for the current fiscal year.

Insider Activity at Heartflow

In related news, CFO Vikram Verghese sold 3,587 shares of the company’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $53.15, for a total transaction of $190,649.05. Following the sale, the chief financial officer owned 149,587 shares in the company, valued at approximately $7,950,549.05. This represents a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Campbell Rogers sold 23,933 shares of the stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the transaction, the insider directly owned 73,453 shares of the company’s stock, valued at $4,040,649.53. This trade represents a 24.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 332,403 shares of company stock valued at $16,602,786. 7.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Heartflow

Several large investors have recently made changes to their positions in HTFL. XXEC Inc. acquired a new position in Heartflow during the second quarter worth $2,524,764,000. BlackRock Inc. acquired a new stake in Heartflow in the second quarter valued at $152,502,000. Bamco Inc. NY acquired a new stake in Heartflow in the second quarter valued at $94,625,000. Jupiter Topco LLC bought a new position in shares of Heartflow in the 2nd quarter valued at about $70,983,000. Finally, Janus Henderson Group PLC grew its position in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the period.

Top Heartflow Stories

These are some of the HTFL stories that stood out recently:

• Positive Sentiment: Q3 revenue rose 57% year over year to $72.9 million, above the roughly $65.2 million consensus. The quarterly loss was $0.03 per share, narrower than analysts’ expected $0.18 loss and the $0.27 loss a year earlier. Q3 results
• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
• Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.